Related Experiment Video
Updated: Apr 18, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Genetic and epigenetic control of RKIP transcription
Ila Datar1, Hanna Tegegne1, Kevin Qin1
1Department of Biochemistry and Cancer Biology, University of Toledo, College of Medicine, Health Science Campus, Toledo, Ohio.
Abstract:
Raf kinase inhibitory protein (RKIP) is known to modulate key signaling cascades and regulate normal physiological processes such as cellular proliferation, differentiation, and apoptosis. The expression of RKIP is found to be downregulated in several cancer metastases and the repressed RKIP expression can be reactivated on treatment with chemotherapeutic agents. RKIP is a proven tumor metastasis suppressor gene and investigating the mechanisms of transcriptional regulation of RKIP is therefore of immense clinical importance. In this review, we discuss the basal expression of RKIP in various tissues and the genetic aspects of the RKIP chromosomal locus including the structure of the RKIP promoter as well as gene regulatory elements such as enhancers. We also review the genetic and epigenetic modulation of RKIP transcription through EZH2, a component of the polycomb repressive complex 2 (PRC2) and sequence specific transcription factors (TFs) BACH1 and Snail. Emerging experimental evidence supports a unifying model in which both these TFs repress RKIP transcription in cancers by recruiting the EZH2 containing repressive complex to the proximal RKIP promoter. Finally, we review the known mechanisms employed by different types of chemotherapeutic agents to activate RKIP expression in cancer cells.
Insights
Raf kinase inhibitory protein (RKIP) suppresses tumors. Its reduced expression in cancer is reversed by chemotherapy, highlighting RKIP
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Raf kinase inhibitory protein (RKIP) regulates cell signaling, proliferation, differentiation, and apoptosis.
- RKIP expression is downregulated in metastatic cancers, but can be restored by chemotherapy.
- RKIP acts as a tumor metastasis suppressor gene, making its transcriptional regulation clinically significant.
Purpose of the Study:
- To review the transcriptional regulation of RKIP, focusing on its promoter structure and regulatory elements.
- To discuss the genetic and epigenetic factors modulating RKIP expression, including EZH2, BACH1, and Snail.
- To present a model for RKIP repression in cancer and review chemotherapy-induced RKIP activation.
Main Methods:
- Review of existing literature on RKIP gene expression, regulation, and function.
- Analysis of RKIP promoter structure and genetic regulatory elements.
- Examination of epigenetic modifiers (EZH2) and transcription factors (BACH1, Snail) involved in RKIP regulation.
Main Results:
- RKIP expression is modulated by signaling cascades and is downregulated in cancer metastasis.
- EZH2, BACH1, and Snail repress RKIP transcription by recruiting repressive complexes to the RKIP promoter.
- Chemotherapeutic agents can reactivate RKIP expression in cancer cells through various mechanisms.
Conclusions:
- Understanding RKIP transcriptional regulation is crucial for cancer therapy.
- A unified model explains RKIP repression by TFs and EZH2 in cancer.
- Targeting RKIP regulatory pathways offers potential therapeutic strategies against cancer metastasis.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Prokaryotic Transcriptional Activators and Repressors

